AGM/EGM9 Jul 2026, 04:50 pm
Asston Pharma to issue 24.1 Lakh Equity Shares on Preferential Basis
AI Summary
Asston Pharmaceuticals Ltd has announced its Second Extraordinary General Meeting (EGM) for FY 2026-27, scheduled for July 31, 2026. The primary agenda is to consider and approve the issuance of up to 24,10,431 equity shares at a price of ₹115 per share on a preferential basis. This move is subject to shareholder approval and regulatory compliance, including SEBI (ICDR) Regulations, 2018. The meeting will be conducted via video conferencing, with July 24, 2026, set as the cut-off date for determining voting eligibility. The company aims to raise capital through this preferential allotment.
Key Highlights
- EGM scheduled for July 31, 2026, to approve preferential share issuance.
- Plan to issue up to 24.1 Lakh equity shares at ₹115 each.
- Meeting to be held via video conferencing with e-voting facility.
- Cut-off date for voting eligibility is July 24, 2026.
- Transaction requires shareholder and regulatory approvals.
Price Impact
More from APL